Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 19.97M P/E - EPS this Y 44.40% Ern Qtrly Grth -
Income -40.16M Forward P/E -0.74 EPS next Y 27.60% 50D Avg Chg -34.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -19.00%
Dividend N/A Price/Book 0.58 EPS next 5Y - 52W High Chg -52.00%
Recommedations 1.70 Quick Ratio 2.51 Shares Outstanding 29.53M 52W Low Chg 49.00%
Insider Own 19.69% ROA -68.72% Shares Float 16.85M Beta 1.20
Inst Own 35.74% ROE -136.38% Shares Shorted/Prior 1.03M/799.87K Price 0.94
Gross Margin - Profit Margin - Avg. Volume 87,761 Target Price 7.00
Oper. Margin - Earnings Date Aug 5 Volume 163,146 Change -7.84%
About Vincerx Pharma, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with relapsed and refractory leukemia and lymphoid malignancies, as well as solid tumors and non-Hodgkin lymphoma; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat advanced or metastatic solid tumors. Its product candidates also include VIP943 in Phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, myelodysplastic syndrome, and B-cell acute lymphoblastic leukemia; and VIP924 in preclinical studies for the treatment of B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 and is based in Palo Alto, California.

Vincerx Pharma, Inc. News
05/14/24 Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
04/25/24 Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
04/25/24 Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
04/09/24 Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
04/09/24 Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
04/08/24 Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
04/01/24 Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
03/29/24 Vincerx Pharma Inc (VINC) Reports Q4 and Full Year 2023 Financials: A Close Look
03/29/24 Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
03/14/24 12 Most Profitable Biotech Stocks To Invest In
03/05/24 Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
03/05/24 Vincerx Pharma, Inc.'s (NASDAQ:VINC) large institutional owners must be happy as stock continues to impress, up 28% over the past week
01/07/24 Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
12/19/23 15 Best Falling Stocks To Buy Now
12/10/23 Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023
11/14/23 Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
08:10 AM Vincerx Pharma To Present Three Posters at ASH 2023 in December
10/13/23 New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network
10/06/23 New to The Street Announces TV Corporate Appearances, Broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ET
09/19/23 Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023
VINC Chatroom

User Image mdrins00 Posted - 21 hours ago

$VINC Seeing posts here about OS and insider ownership. Data from Yahoo, Fintel, FinViz, maybe Thin Air. Why rely on third party sites if you're really interested in accurate data? This is not difficult. Go to Edgar and read their filings; they tell you exactly how many shares are out there and who owns what. And no, there were NOT a bunch of "insider buys" last week. There WERE a bunch of stock options granted to execs and directors. As of 12/31/23, there were 21,407,510 OS. As of March 26, there were 21,413,389 OS. In early April, they sold 2,120,849 via ATM. They sold 6,000,000 shares in their offering (plus 6M common and 16M pre-funded warrants, both of which are not part of OS until they are exercised). Let's assume no warrants have been exercised, that gives us 29,534,238 OS. As for insider ownership, here you go: (this is as of 3/26, before the ATM and offering) Note: GS has since reduced their stake and ProSight participated in the offering and are now a >5% holder.

User Image lllIIIII Posted - 1 day ago

@Super_Pumper_Ape Murder? Murder is what happened at $VINC $CTMX $AMLX $SNSE...etc

User Image Gesundheit Posted - 05/31/24

$VINC there we go. Bought a couple thousand more at closing.

User Image BKEBurgyBuffett Posted - 05/31/24

$VINC I hope Hamdy gets a flat tire every single day until this trash is delisted.

User Image GSHSRWD Posted - 05/31/24

$VINC lol, always wait for eod on Friday. It pukes every week

User Image new_jack Posted - 05/31/24

$VINC a bear den until news……. but i love it though. stick around for a while.

User Image GSHSRWD Posted - 05/31/24

$VINC bon appetit

User Image Kumakei Posted - 05/31/24

@kubota2323 @aku78 I hope so as well. and not a pullback like $VINC instead

User Image Hawa09 Posted - 05/31/24

$VINC what are the chances of delisting?

User Image GSHSRWD Posted - 05/31/24

$VINC

User Image Gesundheit Posted - 05/31/24

$VINC can we steal some 60s today?

User Image lllIIIII Posted - 05/30/24

@telomerase VIP943 targets CD123, which has a record of developing resistance rather easily/volatile reaction (at least for tagraxofusp) in AML, an area which also could be viewed as a saturating market due to large competition. ADC is great, and VIP943 do seem the safest bet out of the $VINC candidates but chance? No clue & not optimistic.

User Image Dtwod7474 Posted - 05/30/24

$VINC I really contemplated buying more at the .64 mark to average down further. Oh well.

User Image GreenTsunami Posted - 05/30/24

$VINC looks like we will be getting results for VIP236 by the end of Q3 which is November 2024 and VIP943 Q4 which is February 2025. I hope we can get some good news at the European conference in two weeks, that is not the same jargon released at the AACR conference. I hope Vincerx is laser focused on working in the lab because they completely botched their focus on financials. Wishing them luck from the sidelines.

User Image TupacLive Posted - 05/30/24

$VINC This has a STRONG BUY rating!! WAKE UP VINC!!

User Image GoGreen21 Posted - 05/30/24

$VINC We all know the big crash is coming soon. Maybe a 50% and all stocks will flash lifetime buy opportunities even the very best so always keep some cash back for that.

User Image moslofu Posted - 05/30/24

$VINC think this bottoms at 0.61 then starts to trend up

User Image GSHSRWD Posted - 05/30/24

$VINC

User Image GoGreen21 Posted - 05/30/24

$VINC Just to be clear I have been with VINC for several years and it is the largest holding that I have of any stock. I really don't have any concerns about the recent price action. For the long haul I am expecting a nice return.

User Image telomerase Posted - 05/30/24

$VINC GoGreen21 is right about Fintel, but I doubt Fintel is right about VINC's insiders... it does indeed show them with 73% of the "company": https://fintel.io/sn/us/vinc

User Image telomerase Posted - 05/30/24

$VINC so far, VINC has re-proved that CDK9 inhibitors don't work and that SMDCs don't exist as a drug class. Now, ADCs actually do exist, and they still have VIP 943... any chance it will work?

User Image telomerase Posted - 05/30/24

$VINC YHOO has insider ownership at 19.69%... link to your "73.09%" figure? TIA https://finance.yahoo.com/quote/VINC/holders/

User Image GoGreen21 Posted - 05/29/24

$VINC Insider statistics for VINC Shares Outstanding 29,534,238 shares Insider Shares 21,585,384 shares Insider Ownership 73.09 % Total Insiders 26

User Image GrandMasterApe Posted - 05/29/24

$VINC Well that’s interesting. Something big in the works here boys.

User Image HoHoHoHum Posted - 05/29/24

@precise dont tell me you have given up on $vinc

User Image S_Franconi Posted - 05/29/24

$VINC 2024-05-15 13F Octagon Capital Advisors LP 1,000,000 5,060 https://fintel.io/so/us/vinc

User Image S_Franconi Posted - 05/29/24

$VINC oh let's see last year I bought 5K at .63 - and held them and banked. Looking for a load point.

User Image precise Posted - 05/29/24

$MAIA I pray that you all do not get $VINC ed. Good luck.

User Image Businesspro Posted - 05/29/24

$VINC Red again what a shocker… Everyday red Going to zero

User Image GSHSRWD Posted - 05/29/24

$VINC

Analyst Ratings
Cantor Fitzgerald Overweight Apr 9, 24
Cantor Fitzgerald Overweight Apr 1, 24
Cantor Fitzgerald Overweight Sep 7, 23
Chardan Capital Buy Nov 17, 22
SVB Leerink Outperform Aug 12, 22
Cantor Fitzgerald Overweight Jun 8, 22
B. Riley Securities Buy Jun 7, 22
Chardan Capital Buy Jun 7, 22
SVB Leerink Outperform Jun 7, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Hamdy Ahmed MD See Remarks See Remarks Aug 09 Buy 0.95 22,300 21,185 96,060 08/10/23
THOMAS TOM C See Remarks See Remarks Aug 10 Buy 0.95 5,000 4,750 219,935 08/10/23
Izumi Raquel E. See Remarks See Remarks Aug 09 Buy 0.92 16,476 15,158 85,214 08/10/23
Izumi Raquel E. See Remarks See Remarks Dec 14 Buy 0.8848 28,738 25,427 68,738 12/14/22
Hamdy Ahmed MD Chief Executive Offi.. Chief Executive Officer Dec 14 Buy 0.8656 35,280 30,538 73,760 12/14/22
THOMAS TOM C See Remarks See Remarks Dec 14 Buy 0.83 7,000 5,810 10,000 12/14/22
Hamdy Ahmed MD Chief Executive Offi.. Chief Executive Officer Jun 23 Buy 1.4106 24,200 34,137 38,480 06/27/22
Bushnell Laura I. Director Director Jun 09 Buy 1.9083 15,000 28,624 19,202 06/13/22